论文部分内容阅读
近些年来，糖化血红蛋白( HbA1c )作为糖尿病筛查、病情控制、随访监测及疗效评估的有效检测指标，已经在临床中得到了广泛的应用，因其研究的局限性，目前我国未将HbA1c作为糖尿病的诊断标准，但因其能更好反映长期血糖平均水平，故有较好的临床研究前景。希望未来有大样本的前瞻性研究，从而得出最适合中国群的最佳灵敏度和特异度的糖尿病诊断标准。“,”In recent years,glycosylated hemoglobin(HbA1c),as an effective detection index to diabetes screening,disease control,follow-up monitoring and curative effect evaluation,has been widely used in clinical practice. Because of the limitation of the research about HbA1c ,HbA1c has not been made as a diagnostic crite-ria for diabetes in China,but due to its better reflection of the long-term average blood sugar level,it has a good prospect for future clinical application. Large sample prospective studies in the future are expected to achieve a diagnostic criteria with the best sensitivity and specificity and most suitable for the Chinese population.